Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnolia Study: Zoledronic Acid Duration in Multiple Myeloma
NCT02286830Phase 4Completed
- Start
- Jan 2015
- Primary completion
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of zoledronic acid in multiple myeloma (MM). Started Jan 2015; status: completed.
02
Drugs
zoledronic acid
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT02286830.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02286830.